cbdMD, Inc. Quarterly Operating Income (Loss) in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
cbdMD, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2016 to Q3 2024.
  • cbdMD, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$317K, a 97.9% increase year-over-year.
  • cbdMD, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.32M, a 85.3% increase year-over-year.
  • cbdMD, Inc. annual Operating Income (Loss) for 2024 was -$3.32M, a 85.3% increase from 2023.
  • cbdMD, Inc. annual Operating Income (Loss) for 2023 was -$22.5M, a 71.3% increase from 2022.
  • cbdMD, Inc. annual Operating Income (Loss) for 2022 was -$78.3M, a 299% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.32M -$317K +$14.9M +97.9% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-18
Q2 2024 -$18.2M -$382K +$1.44M +79.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$19.7M -$1.55M -$150K -10.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$19.5M -$1.07M +$2.98M +73.7% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$22.5M -$15.2M -$233K -1.55% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-18
Q2 2023 -$22.3M -$1.82M +$31.3M +94.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$53.6M -$1.4M +$3.61M +72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$57.2M -$4.05M +$21.1M +83.9% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$78.3M -$15M -$7.97M -114% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-22
Q2 2022 -$70.3M -$33.1M -$26.5M -396% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$43.8M -$5.01M -$843K -20.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$43M -$25.1M -$23.4M -1329% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$19.6M -$7.01M -$2.48M -54.8% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-15
Q2 2021 -$17.1M -$6.68M -$5.34M -399% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$11.8M -$4.17M +$1.43M +25.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$13.2M -$1.76M +$4.35M +71.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$17.6M -$4.53M +$680K +13% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-17
Q2 2020 -$18.3M -$1.34M +$5.13M +79.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$23.4M -$5.6M -$3.57M -176% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$19.8M -$6.11M -$5.02M -460% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$14.8M -$5.21M -$2.46M -89.7% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-22
Q2 2019 -$12.3M -$6.47M -$7.09M -1131% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$5.24M -$2.03M -$3.65M -225% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$1.59M -$1.09M +$206K +15.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$1.8M -$2.75M -$2.47M -896% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-18
Q2 2018 $674K $627K +$806K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$132K $1.62M +$1.83M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.96M -$1.3M -$602K -86.6% Oct 1, 2017 Dec 31, 2017 10-Q/A 2019-04-26
Q3 2017 -$1.36M -$276K Jul 1, 2017 Sep 30, 2017 10-K 2018-12-12
Q2 2017 -$179K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$211K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$695K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.